{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:32:53Z","timestamp":1777383173391,"version":"3.51.4"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Pathol"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1309\/1u61jvxtlppq7yp1","type":"journal-article","created":{"date-parts":[[2007,5,18]],"date-time":"2007-05-18T00:44:55Z","timestamp":1179449095000},"page":"977-981","source":"Crossref","is-referenced-by-count":22,"title":["A Simple, Rapid, and Sensitive Method for the Detection of the<i>JAK2<\/i>V617F Mutation"],"prefix":"10.1093","volume":"127","author":[{"given":"Angela Y.C.","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Westerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Dobrovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,6,1]]},"reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Rane SG, Reddy EP. Janus kinases: components of multiple signaling pathways. <i>Oncogene.<\/i> 2000; <b>19<\/b>:5662-5679.","DOI":"10.1038\/sj.onc.1203925"},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"James C, Ugo V, Le Couedic JP, et al. A unique clonal <i>JAK2<\/i> mutation leading to constitutive signalling causes polycythaemia vera. <i>Nature.<\/i> 2005; <b>434<\/b>:1144-1148.","DOI":"10.1038\/nature03546"},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Levine RL, Wadleigh M, Cools J, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. <i>Cancer Cell.<\/i> 2005; <b>7<\/b>:387-397.","DOI":"10.1016\/j.ccr.2005.03.023"},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. <i>Lancet.<\/i> 2005; <b>365<\/b>:1054-1061.","DOI":"10.1016\/S0140-6736(05)71142-9"},{"key":"E00005","doi-asserted-by":"crossref","unstructured":"Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of <i>JAK2<\/i> in myeloproliferative disorders. <i>N Engl J Med.<\/i> 2005; <b>352<\/b>:1779-1790.","DOI":"10.1056\/NEJMoa051113"},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Steensma DP, Dewald GW, Lasho TL, et al. The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \"atypical\" myeloproliferative disorders and myelodysplastic syndromes. <i>Blood.<\/i> 2005; <b>106<\/b>:1207-1209.","DOI":"10.1182\/blood-2005-03-1183"},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Jones AV, Kreil S, Zoi K, et al. Widespread occurrence of the <i>JAK2<\/i> V617F mutation in chronic myeloproliferative disorders. <i>Blood.<\/i> 2005; <b>106<\/b>:2162-2168.","DOI":"10.1182\/blood-2005-03-1320"},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"Jelinek J, Oki Y, Gharibyan V, et al. <i>JAK2<\/i> mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia. <i>Blood.<\/i> 2005; <b>106<\/b>:3370-3373.","DOI":"10.1182\/blood-2005-05-1800"},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"Kaushansky K. On the molecular origins of the chronic myeloproliferative disorders: it all makes sense. <i>Blood.<\/i> 2005; <b>105<\/b>:4187-4190.","DOI":"10.1182\/blood-2005-03-1287"},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Tefferi A, Gilliland D. The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis. <i>Mayo Clin Proc.<\/i> 2005; <b>80<\/b>:947-958.","DOI":"10.4065\/80.7.947"},{"key":"E00011","doi-asserted-by":"crossref","unstructured":"Greiner TC. Diagnostic assays for the <i>JAK2<\/i> V617F mutation in chronic myeloproliferative disorders [editorial]. <i>Am J Clin Pathol.<\/i> 2006; <b>125<\/b>:651-653.","DOI":"10.1309\/NXXT-GRCX-D0TM-A3C2"},{"key":"E00012","doi-asserted-by":"crossref","unstructured":"Campbell PJ, Scott LM, Baxter EJ, et al. Methods for the detection of the <i>JAK2<\/i> V617F mutation in human myeloproliferative disorders. In: Iland H, Hertzberg M, Marlton P, eds. <i>Methods in Molecular Medicine: Myeloid Leukemia: Methods and Protocols.<\/i> Vol 125. Totowa, NJ: Humana Press; 2006:253-264.","DOI":"10.1385\/1-59745-017-0:253"},{"key":"E00013","doi-asserted-by":"crossref","unstructured":"Bock O, Busche G, Koop C, et al. Detection of the single hotspot mutation in the JH2 pseudokinase domain of Janus kinase 2 in bone marrow trephine biopsies derived from chronic myeloproliferative disorders. <i>J Mol Diagn.<\/i> 2006; <b>8<\/b>:170-177.","DOI":"10.2353\/jmoldx.2006.050064"},{"key":"E00014","doi-asserted-by":"crossref","unstructured":"James C, Delhommeau F, Marzac C, et al. Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis. <i>Leukemia.<\/i> 2006; <b>20<\/b>:350-353.","DOI":"10.1038\/sj.leu.2404069"},{"key":"E00015","doi-asserted-by":"crossref","unstructured":"Murugesan G, Aboudola S, Szpurka H, et al. Identification of the <i>JAK2<\/i> V617F mutation in chronic myeloproliferative disorders using FRET probes and melting curve analysis. <i>Am J Clin Pathol.<\/i> 2006; <b>125<\/b>:625-633.","DOI":"10.1309\/TK0X-L917-XK2V-LRPQ"},{"key":"E00016","doi-asserted-by":"crossref","unstructured":"McClure R, Mai M, Lasho T. Validation of two clinically useful assays for evaluation of <i>JAK2<\/i> V617F mutation in chronic myeloproliferative disorders. <i>Leukemia.<\/i> 2006; <b>20<\/b>:168-171.","DOI":"10.1038\/sj.leu.2404007"},{"key":"E00017","doi-asserted-by":"crossref","unstructured":"Sattler M, Walz C, Crowley BJ, et al. A sensitive high-throughput method to detect activating mutations of Jak2 in peripheral-blood samples [letter]. <i>Blood.<\/i> 2006; <b>107<\/b>:1237-1238.","DOI":"10.1182\/blood-2005-07-2899"},{"key":"E00018","doi-asserted-by":"crossref","unstructured":"Tan A, Westerman D, McArthur GA, et al. Sensitive detection of KIT D816V in patients with mastocytosis. <i>Clin Chem.<\/i> 2006; <b>52<\/b>:2250-2257.","DOI":"10.1373\/clinchem.2006.068205"},{"key":"E00019","doi-asserted-by":"crossref","unstructured":"Orou A, Fechner B, Utermann G, et al. Allele-specific competitive blocker PCR: a one-step method with applicability to pool screening. <i>Hum Mutat.<\/i> 1995; <b>6<\/b>:163-169.","DOI":"10.1002\/humu.1380060209"},{"key":"E00020","doi-asserted-by":"crossref","unstructured":"Newton CR, Graham A, Heptinstall LE, et al. Analysis of any point mutation in DNA: the amplification refractory mutation system (ARMS). <i>Nucleic Acids Res.<\/i> 1989; <b>17<\/b>:2503-2516.","DOI":"10.1093\/nar\/17.7.2503"},{"key":"E00021","unstructured":"Nollau P, Wagener C. Methods for detection of point mutations: performance and quality assessment. The IFCC Scientific Division, Committee on Molecular Biology Techniques. <i>J Int Fed Clin Chem.<\/i> 1997; <b>9<\/b>:162-170."},{"key":"E00022","doi-asserted-by":"crossref","unstructured":"Imyanitov EN, Buslov KG, Suspitsin EN, et al. Improved reliability of allele-specific PCR. <i>Biotechniques.<\/i> 2002; <b>33<\/b>:484, 486, 488, passim.","DOI":"10.2144\/02333bm04"},{"key":"E00023","doi-asserted-by":"crossref","unstructured":"Lasho TL, Mesa R, Gilliland DG, et al. Mutation studies in CD3+, CD19+ and CD34+ cell fractions in myeloproliferative disorders with homozygous JAK2(V617F) in granulocytes. <i>Br J Haematol.<\/i> 2005; <b>130<\/b>:797-799.","DOI":"10.1111\/j.1365-2141.2005.05682.x"},{"key":"E00024","doi-asserted-by":"crossref","unstructured":"Stevenson WS, Hoyt R, Bell A, et al. Genetic heterogeneity of granulocytes for the <i>JAK2<\/i> V617F mutation in essential thrombocythaemia: implications for mutation detection in peripheral blood. <i>Pathology.<\/i> 2006; <b>38<\/b>:336-342.","DOI":"10.1080\/00313020600820906"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/127\/6\/977\/4988468\/ajcpath127-0977.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T22:15:55Z","timestamp":1683843355000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1309\/1U61JVXTLPPQ7YP1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2007,6,1]]},"published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1309\/1U61JVXTLPPQ7YP1"],"URL":"https:\/\/doi.org\/10.1309\/1u61jvxtlppq7yp1","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}